683 Capital Management’s Wave Life Sciences WVE Stock Holding History

683 Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8M	Buy	4,950,000 +50,000	+1%	+$332K	1.41%	20
2026 Q1	$35.5M	Buy	4,900,000 +885,000	+22%	+$11.5M	1.85%	12
2025 Q4	$68.3M	Sell	4,015,000 -135,000	-3%	-$1.37M	2.97%	6
2025 Q3	$30.4M	Buy	4,150,000 +50,000	+1%	+$405K	1.59%	18
2025 Q2	$26.7M	Buy	4,100,000 +175,000	+4%	+$1.16M	1.75%	15
2025 Q1	$31.7M	Buy	3,925,000 +140,000	+4%	+$1.53M	2.19%	10
2024 Q4	$46.8M	Sell	3,785,000 -415,000	-10%	-$5.54M	2.9%	5
2024 Q3	$34.4M	Sell	4,200,000 -1,125,000	-21%	-$6.72M	2.62%	8
2024 Q2	$26.6M	Sell	5,325,000 -25,000	-0.5%	-$143K	2.01%	12
2024 Q1	$33M	Sell	5,350,000 -250,000	-4%	-$1.25M	2.42%	11
2023 Q4	$28.3M	Sell	5,600,000 -250,000	-4%	-$1.34M	2.32%	10
2023 Q3	$33.6M	Sell	5,850,000 -181,000	-3%	-$826K	2.62%	6
2023 Q2	$22M	Buy	6,031,000 +31,000	+0.5%	+$125K	1.58%	19
2023 Q1	$26M	Hold	6,000,000	–	–	1.94%	10
2022 Q4	$42M	Sell	6,000,000 -1,622,348	-21%	-$7.48M	3.55%	3
2022 Q3	$27.5M	Buy	7,622,348 +101,100	+1%	+$335K	2.13%	10
2022 Q2	$24.4M	Buy	7,521,248 +7,059,201	+1,528%	+$13.6M	1.73%	14
2022 Q1	$924K	Buy	462,047 +274,919	+147%	+$673K	0.05%	172
2021 Q4	$588K	Sell	187,128 -375,842	-67%	-$1.56M	0.02%	193
2021 Q3	$2.76M	Buy	562,970 +62,970	+13%	+$382K	0.11%	102
2021 Q2	$3.33M	Buy	+500,000	New	+$3.27M	0.12%	99

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

683 Capital Management's WVE Position: Q2 2026 in Review

683 Capital Management increased its Wave Life Sciences (WVE) stake by 1% in Q2 2026, buying an estimated $332K and bringing the position to 4,950,000 shares worth $28.8M. The position accounts for 1.41% of the portfolio, ranked #20.

683 Capital Management first reported a position in WVE in Q2 2021 and has held it in 21 quarters since. The position peaked at $68.3M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

683 Capital Management held 4,950,000 shares of Wave Life Sciences worth $28.8M as of Q2 2026.
683 Capital Management bought 50,000 Wave Life Sciences shares in Q2 2026, an estimated $332K.
Wave Life Sciences made up 1.41% of 683 Capital Management's portfolio in Q2 2026, its #20 holding.
683 Capital Management first reported a position in Wave Life Sciences in Q2 2021 and has held it in 21 quarters since.
683 Capital Management's Wave Life Sciences position peaked at $68.3M in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.